Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

v3.10.0.1
Document and Entity Information - shares
3 Months Ended
Dec. 31, 2018
Feb. 08, 2019
Document and Entity Information [Abstract]    
Entity Registrant Name Citius Pharmaceuticals, Inc.  
Entity Central Index Key 0001506251  
Trading Symbol CTXR  
Amendment Flag false  
Current Fiscal Year End Date --09-30  
Document Type 10-Q  
Document Period End Date Dec. 31, 2018  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2019  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Ex Transition Period false  
Entity Common Stock, Shares Outstanding   18,520,360